# Sandipan Bhattacharjee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sandipan-bhattacharjee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,523 |
| Field | Pharmaceutical Practices and Patient Outcomes |
| h-index | 19 |
| i10-index | 40 |
| Last Known Institution | Otsuka (United States) |
| OpenAlex ID | https://openalex.org/A5026440477 |
| ORCID iD | 0000-0003-4917-5138 |
| Works | 143 |

## Researcher papers

- [<i>BRCA1</i>and<i>BRCA2</i>Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis](https://scholariq.org/papers/i-brca1-i-and-i-brca2-i-gene-mutations-and-colorectal-cancer-risk-systematic/)
- [A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-the-efficacy-and-safety-of-the/)
- [Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis](https://scholariq.org/papers/health-related-quality-of-life-among-myocardial-infarction-survivors-in-the/)
- [Antidepressant use and new‐onset diabetes: a systematic review and meta‐analysis](https://scholariq.org/papers/antidepressant-use-and-new-onset-diabetes-a-systematic-review-and-meta-analysis/)
- [Prevalence and Predictors of Antidepressant Prescribing in Nursing Home Residents in the United States](https://scholariq.org/papers/prevalence-and-predictors-of-antidepressant-prescribing-in-nursing-home/)
- [Depression Screening Patterns, Predictors, and Trends Among Adults Without a Depression Diagnosis in Ambulatory Settings in the United States](https://scholariq.org/papers/depression-screening-patterns-predictors-and-trends-among-adults-without-a/)
- [30-Day Readmission Among Elderly Medicare Beneficiaries with Type 2 Diabetes](https://scholariq.org/papers/30-day-readmission-among-elderly-medicare-beneficiaries-with-type-2-diabetes/)
- [Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016](https://scholariq.org/papers/trends-patient-and-prescriber-characteristics-in-gabapentinoid-use-in-a-sample/)
- [Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors](https://scholariq.org/papers/risk-of-infections-and-cancer-in-patients-with-rheumatologic-diseases-receiving/)
- [Dual‐trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study](https://scholariq.org/papers/dual-trajectories-of-opioid-and-gabapentinoid-use-and-risk-of-subsequent-drug/)
- [Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries](https://scholariq.org/papers/review-on-epidemiology-disease-burden-and-treatment-patterns-of-iga-nephropathy/)
- [The incidence and prevalence of immunoglobulin A nephropathy in the United States](https://scholariq.org/papers/the-incidence-and-prevalence-of-immunoglobulin-a-nephropathy-in-the-united/)

## Researcher topics

- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Mental Health Treatment and Access](https://scholariq.org/topics/mental-health-treatment-and-access/)

## Researcher university

- [Otsuka (United States)](https://scholariq.org/institutions/otsuka-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.